Tomoko Goto

Tokorozawa, 3598513, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Optimization of Aspiration Pressure in Oocyte Retrieval Using Reduced Needles.

Optimization of Aspiration Pressure in Oocyte Retrieval Using Reduced Needles.

Journal: Cureus

Published: September 11, 2025

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

Journal: Oncology letters

Published: June 08, 2017

Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?

Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?

Journal: Cancer chemotherapy and pharmacology

Published: February 15, 2017

Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers.

Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers.

Journal: Cancer chemotherapy and pharmacology

Published: January 25, 2017

Factors favouring long-term survival following recurrence in ovarian cancer.

Factors favouring long-term survival following recurrence in ovarian cancer.

Journal: Molecular and clinical oncology

Published: August 17, 2016

Dedifferentiated endometrioid adenocarcinoma of the uterus: a case report.

Dedifferentiated endometrioid adenocarcinoma of the uterus: a case report.

Journal: European journal of gynaecological oncology

Published: June 29, 2016

Effect of ARID1A/BAF250a expression on carcinogenesis and clinicopathological factors in pure-type clear cell adenocarcinoma of the ovary.

Effect of ARID1A/BAF250a expression on carcinogenesis and clinicopathological factors in pure-type clear cell adenocarcinoma of the ovary.

Journal: Molecular and clinical oncology

Published: March 09, 2016

Is Modified Radical Hysterectomy Needed for Patients with Clinical Stage I/II Endometrial Cancers? A Historical Control Study.

Is Modified Radical Hysterectomy Needed for Patients with Clinical Stage I/II Endometrial Cancers? A Historical Control Study.

Journal: Oncology

Published: December 08, 2015

DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers.

DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers.

Journal: Journal of gynecologic oncology

Published: May 19, 2014

Weekly administration of bevacizumab, gemcitabine, and oxaliplatin in patients with recurrent and refractory ovarian cancer: a preliminary result of 19 cases.

Weekly administration of bevacizumab, gemcitabine, and oxaliplatin in patients with recurrent and refractory ovarian cancer: a preliminary result of 19 cases.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 30, 2013

Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic review.

Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic review.

Journal: Journal of gynecologic oncology

Published: July 09, 2012

Outcomes of palliative bowel surgery for malignant bowel obstruction in patients with gynecological malignancy.

Outcomes of palliative bowel surgery for malignant bowel obstruction in patients with gynecological malignancy.

Journal: Oncology letters

Published: March 16, 2012

Showing 1-12 of 33

Last Updated: 09/26/2026